trending Market Intelligence /marketintelligence/en/news-insights/trending/Y2vM4ZiaPFS1o_reDOrFew2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

AstraZeneca appoints nonexecutive director

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

AstraZeneca appoints nonexecutive director

AstraZeneca PLC said it appointed Michel Demaré to be a nonexecutive director and a member of its audit committee, effective Sept. 1.

Demaré was vice chairman of UBS Group AG from 2010 to 2019. He also served as CFO of Switzerland's ABB Ltd., an electrical equipment company, from Jan. 1, 2005, to Jan. 31, 2013.

Before that, he was CFO for Europe operations and vice president at Deerfield, Ill.-based healthcare equipment company Baxter International Inc. from 2002 to 2005.

Demaré is also a nonexecutive director of Vodafone Group PLC and a member of the supervisory board of Louis Dreyfus Commodities Holdings BV.

U.K.-based drugmaker AstraZeneca develops medicines to treat various kinds of cancer, respiratory illnesses and cardiovascular, renal and metabolism-related diseases.